International Aids Vaccine Initiative Inc
Donations deductibleRevenue
$103.4m
year to 31 December 2025
Expenses
$107.3m
year to 31 December 2025
Total assets
$140.6m
$91.8m liabilities
Net assets
$48.8m
assets less liabilities
Directors and trustees
14
7.8 years on average
Staff
239
13 volunteers
Chair observed
≥6 yrs
Eric Paul Goosby
Left since last filing
0
no seats appear to have opened
International Aids Vaccine Initiative Inc's network
14 people6 organisationsi14 people and 6 organisations on this map.The large node is the subject of this page. Solid lines are what the register itself records (14). Violet dotted lines (6) are likely: the same full name sits on the current board of another organisation in the same register and region. Form 990 filings give names without a person identifier; SEC insider filings carry a CIK. It may be a different person.The board
14 listediTime on the board is observed from the annual filings: the IRS files no appointment date, so the bar counts years from the first filing the person appears on - a lower bound, not a filed start date. Names are exactly as filed. The IRS publishes no person identifier, so this edition does not yet link a person across organisations in the tables. The network map shows same-name matches as likely links only, never as confirmed.Time served and departures are observed across annual filings. Observed time served is a lower bound - a member may have joined before the first year on record. The organisation reported 14 voting members of its governing body on its latest Form 990 Part VI, which matches the board listed here.| Name | Role as filed | Since | On the board |
|---|---|---|---|
| Eric Paul Goosby Chair | Board Chair | 2018 | 8 yrs |
| Alexis M Pinto | Board Member | 2021 | 5 yrs |
| Anne Martin Simonds | Board Member | 2018 | 8 yrs |
| David Blumberg | Board Member | 2018 | 8 yrs |
| Jim Connolly | Board Member | 2018 | 8 yrs |
| John W Shiver | Board Member | 2018 | 8 yrs |
| Linda-Gail Becker | Board Member | 2018 | 8 yrs |
| Marijke Wijnroks | Board Member | 2018 | 8 yrs |
| Mark B Feinberg (also filed as Mark Feinberg) | President/CEO | 2018 | 8 yrs |
| Mark Dybul | Board Member | 2018 | 8 yrs |
| Rajeev Venkayya | Board Member | 2018 | 8 yrs |
| Robert Goldberg | Board Treasurer | 2018 | 8 yrs |
| Susan Silbermann | Board Member | 2021 | 5 yrs |
| Wafaa El-Sadr | Board Member | 2021 | 5 yrs |
Officers and senior leadership
20 listediNamed in Part VII as officers, key employees or highest-compensated staff - not board members, shown for completeness.| Name | Title as filed | On the filings |
|---|---|---|
| ANA Cespedes Montoya | Chief Operating Officer (From 9/18) | since 2018 |
| Ann Ginsberg | Senior Technical Advisor | 2019 |
| Anthony Musyoka | H.R., Asst. Secretary (Until 8/18) | 2018 |
| Brandon Saft | Deputy Chief Financial Officer | 2024 |
| Christopher Parks | Executive Dir., Viral Vaccines | since 2018 |
| Christopher Parks - Assoc | VP, Viral Vaccines & Head of the DDL | since 2022 |
| Dagna Laufer | VP and Head of Clinical Development | since 2020 |
| Eric Skjeveland | VP, Business Development | since 2022 |
| Frances Priddy | Executive Dir, Chief Medical Officer | 2018 |
| Frances Sinha | Cpo, VP of HR (Until 12/1/22) | since 2019 |
| Labeeb Abboud | Secretary, Sr VP, General Counsel | since 2018 |
| Louis D Schwartz | Chief Financial Officer | since 2018 |
| Margaret T Keane | VP Global All. & Prod. Optimization | since 2018 |
| Mario Gagliano | Cpo, VP of HR (From 9/23) | since 2023 |
| Marion Gruber | VP, Public Health & Reg. Science | 2024 |
| MIN Ding | General Counsel/Board Secretary | since 2022 |
| Sangeetha Sagar | VP & Head of Product Dev | since 2023 |
| Swati Gupta | VP, Head of Eid and Epidemiology | since 2018 |
| Thomas Hassell | VP, Vaccine Development R&D | since 2018 |
| William Ballou | Adv Sr Sci Adv/Proj Lead, Hiv Bnabs | 2021 |
Pay and hours
year to 31 December 2025iFrom Part VII of the Form 990: compensation reported for each officer, director, trustee, key employee and highest-paid staff member, and the average hours a week they report. Most board members are unpaid; a blank means nothing was reported. Pay from related organisations is shown separately.| Name | Title as filed | Hours a week | Pay from the organisation | Related organisations | Other |
|---|---|---|---|---|---|
| Mark B Feinberg | President/CEO | 35 | $706k | $61k | |
| Kara Bickham | Chief Dev. Officer- Research Dev. | 35 | $415k | $64k | |
| Swati Gupta | VP, Head of Eid and Epidemiology | 35 | $394k | $51k | |
| Christopher Parksass VP | Viral Vacc. & Head of DDL | 35 | $377k | $51k | |
| Jon Heinrichs | VP, Discovery Science | 35 | $374k | $58k | |
| Mario Gagliano | Chief People Officer, VP of HR | 35 | $368k | $59k | |
| Min Ding | General Counsel / Board Secretary | 35 | $357k | $66k | |
| Richard W Welch | VP, Bioprocess Dev. & MFG. | 35 | $346k | $43k | |
| Brandon Saft | Chief Financial Officer | 35 | $332k | $41k | |
| Ana Cespedes Montoya | Chief Operating Officer (End 3/25) | 35 | $170k | $19k | |
| Louis D Schwartzasst Sec | CHF.Fin. & Admin Off. (End 1/25) | 35 | $3k | $105 | |
| Eric Paul Goosby MD | Board Chair | 2 | $0 | ||
| Robert Goldberg | Board Treasurer | 2 | $0 | ||
| Linda- Gail Becker | Board Member | 1 | $0 | ||
| David Blumberg | Board Member | 1 | $0 | ||
| Jim Connolly | Board Member | 1 | $0 | ||
| Alexis M Pinto | Board Member | 1 | $0 | ||
| John W Shiver | Board Member | 1 | $0 | ||
| Susan Silbermann | Board Member | 1 | $0 | ||
| Anne Martin Simonds | Board Member | 1 | $0 | ||
| Rajeev Venkayya | Board Member | 1 | $0 | ||
| Marijke Wijnroks | Board Member | 1 | $0 | ||
| Hon Mark Dybul | Board Member | 1 | $0 | ||
| Wafaa El-Sadr | Board Member | 1 | $0 |
Colorado roster
11 listediOfficers, directors and trustees from the latest filing with the Colorado Secretary of State (document 20243025458). Titles are as filed; some entries are registered agents or custodians of records rather than board members. Source: data.colorado.gov, public domain.| Name | Title as filed |
|---|---|
| David L. Blumberg | Board Member |
| Linda-Gail Bekker, PhD | Board Member |
| Robert Goldberg | Board Treasurer |
| Hon. Mark Dybul | Board Member |
| Ana Cespedes | Chief Operating Officer |
| Mark B. Feinberg | President and CEO |
| Eric Paul Goosby, MD | Board Chair |
| Louis D. Schwartz | Chief Financial Officer and Administrative Officer |
| Eileen P. Rose, MBA | Associate Director, Purchasing and Facilities |
| Louis D. Schwartz | |
| Jim Connolly | Board Member |
About
- Legal name
- International Aids Vaccine Initiative Inc
- EIN
- 133870223
- Address
- 125 Broad Street 9th Floor, New York, NY, 10004-2743
- State
- New York
- Mission
- A global nonprofit biomedical research organization that develops vaccines and antibodies for hiv, tuberculosis, and emerging infectious diseases. (as filed on the Form 990)
- Activity (NTEE)
- Q300 International, foreign affairs and national security
- IRS classification
- 501(c)03 (tax-exempt under section 501(c)(3) where shown)
- Classified purpose
- International, Foreign Affairs & National Security
- Size band
- 9 (IRS master file code)
- Formed
- 1996
- Principal officer
- Mark B Feinberg (as named on the Form 990)
- IRS ruling date
- 1 July 1996
- Status
- Code 01 (unconditional exemption)
- Form 990 filings on record
- 7, latest 2024
- IRS Publication 78
- PC (contributions deductible)
Most connected
Longest observed on the filings
≥8years on the filingsEric Paul Goosby
≥8years on the filingsAnne Martin Simonds
≥8years on the filingsDavid Blumberg
≥8years on the filingsJim Connolly
Latest return
year to 31 December 2025iFigures from the newest Form 990 or 990-EZ in the IRS e-file releases of 2025 and 2026, for the year ending 31 December 2025. US dollars, as filed.- Total assets
- $140.6m
- Total liabilities
- $91.8m
- Net assets or fund balances
- $48.8m
- Contributions and grants received
- $99.4m
- Program service revenue
- $1.2m
- Grants and similar paid out
- $27.2m
- Employees
- 239
- Volunteers
- 13
Filed finances
1 yeariTotals as filed on the IRS Form 990 (revenue and expenses), by tax year.| Tax year | Total revenue | Total expenses | Surplus or deficit |
|---|---|---|---|
| 2024 | $131.2m | $143m | Deficit $11.9m |
As filed on the IRS Form 990. US dollars.
Grants paid
8 listediFrom Schedule I of the Form 990: grants and assistance to organisations in the United States, largest first (up to 25). Schedule I is filed only by organisations that gave more than $5,000 to any one recipient.| Recipient | Purpose | Amount |
|---|---|---|
| The Scripps Research Institute - Osp | Research & development | $2.5m |
| Fhi Clinical Inc | Research & development | $1.2m |
| The Mitchell Group Inc (TMG) | Research & development | $923k |
| Seattle Children's Hospital | Research & development | $674k |
| Trustees of Boston University | Research & development | $414k |
| La Jolla Institute for Allergy & Immunology | Research & development | $401k |
| Emory University | Research & development | $43k |
| Suny Graduate School | Research & development | $39k |
State registration
1 entityiBusiness-entity registers published by US states. These records are matched to this organisation by name and state, not by EIN, and are labelled as likely matches. Street addresses are not shown.International Aids Vaccine Initiative Inc. likely matchiMatched by exact name and state (and ZIP where shown). State registers do not publish EINs, so this is not a confirmed match. Source: New York Department of State, active corporations (data.ny.gov n9v6-gdp6). Licence: New York open data terms of use. Data last fetched 18 October 2026.
- State
- New York
- Entity type
- Foreign Not-For-Profit Corporation
- Status
- Active
- Formed
- 14 February 1997
- Registered agent
- Not stated